Jan Verheijen Selected Research

Jan Verheijen Research Topics

3	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 11/2019 - 01/2019
3	Alzheimer Disease (Alzheimer's Disease) 09/2017 - 12/2015
1	Diabetic Neuropathies (Diabetic Neuropathy) 11/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2019
1	Muscular Diseases (Myopathy) 01/2019
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2019
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Glycogen Storage Disease XIV 01/2019
1	Memory Disorders (Memory Loss) 01/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018
1	Frontotemporal Dementia (Semantic Dementia) 01/2018
1	Genetic Risk Score 12/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2010
1	Atherosclerotic Plaque (Atheroma) 01/2006
1	Atherosclerosis 10/2003

2	EnzymesIBA 11/2019 - 01/2019
2	GlycogenIBA 01/2019 - 01/2019
1	Congenital disorder of glycosylation type 1AIBA 11/2019
1	Aldehyde Reductase (Aldose Reductase)IBA 11/2019
1	epalrestatIBA 11/2019
1	Hemostatics (Antihemorrhagics)IBA 01/2019
1	PhosphoglucomutaseIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 09/2017
1	Nonsense Codon (Nonsense Mutation)IBA 09/2017
1	sortilinIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 12/2015
1	NucleotidesIBA 12/2015
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2010
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2006
1	CollagenIBA 01/2006
1	Matrix Metalloproteinases (MMPs)IBA 01/2006
1	Plasminogen Activators (Plasminogen Activator)IBA 10/2003
1	CholesterolIBA 10/2003
1	PlasminogenIBA 10/2003
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2003
1	LipidsIBA 10/2003
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2003
1	Plasminogen Activator Inhibitor 1IBA 10/2003
1	Fibrinolysin FDA Link 10/2003